Related Experiment Video
Updated: Mar 30, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.7K
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
James J Harding1,2, Imane El Dika3, Ghassan K Abou-Alfa1,2
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer
|November 6, 2015
Summary
Advanced hepatocellular carcinoma (HCC) treatment options are limited. Novel immunotherapies show promise in early trials by overcoming immune barriers and enhancing anti-tumor responses for better patient outcomes.
Area of Science:
- Hepatobiliary cancers
- Cancer immunology
- Translational oncology
Background:
- Advanced hepatocellular carcinoma (HCC) has a poor prognosis with limited treatment efficacy.
- Current therapies, like sorafenib, offer modest benefits.
- Immunologic mechanisms contribute to HCC progression and immune evasion.
Purpose of the Study:
- To review barriers to effective anti-HCC immune responses.
- To discuss novel immunotherapeutic strategies for HCC.
- To evaluate the potential of these strategies in altering HCC's natural history.
Main Methods:
- Literature review of preclinical data on HCC immunology.
- Analysis of current clinical investigations into immunotherapies for HCC.
- Synthesis of information on immune evasion mechanisms in HCC.
Main Results:
- Preclinical studies reveal immune system involvement in HCC growth.
- Early-phase clinical trials of immunomodulatory approaches show therapeutic promise.
- Identification of key barriers to successful anti-tumor immunity in HCC.
Conclusions:
- Harnessing the immune system offers a promising avenue for HCC treatment.
- Overcoming immune suppression is crucial for improving patient outcomes.
- Further research into novel immunotherapies is warranted for advanced HCC.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K